Madrigal Pharmaceuticals Inc (MDGL)
SBC to Revenue
9.71%
Quarterly · Period ending:
MDGL SBC to Revenue
Latest reported9.71%period ending
Latest reported9.71%period ending
MDGL Quarterly SBC/Revenue (0.00% → 9.71%)
Latest values, visible window
High-resolution chart · PNG
MDGL sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 9.7106% | |
| 10.9264% | |
| 0% | |
| 9.1385% | |
| 11.8227% | |
| 15.2503% | |
| 17.108% | |
| 28.7865% | |
| 166.7168% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 12.9488% | |
| 0% | |
| 0% | |
| 562.585% | |
| 24.7736% | |
| 52.1034% | |
| 59.9705% | |
| 72.3535% | |
| 21.3773% | |
| 28.4659% | |
| 33.7798% | |
| 27.0196% | |
| 23.8248% | |
| 0.9601% | |
| 22.5161% | |
| 25.8315% | |
| 1,190.566% | |
| 0% | |
| 0% | |
| 159.6413% | |
| 729.0713% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |